Value of Irish mergers and acquisitions falls more than 50% 

The slump in mergers and acquisitions is said to be due to a number of factors including rising interest rates, high inflation and fears of recession

The largest deal recorded so far this year was the  acquisition of Amryt Pharma by Italy’s Chiesi Farmaceutici for €1.34bn. 

The value of merger and acquisition activity in Ireland has dropped by over 50% during the first six months of the year while the number of transactions dropped 2%, new figures show.

The figures were contained in law firm William Fry’s half-year review into merger and acquisition activity in Ireland. It found, between January and the end of June, there were a total of 177 transactions valued at €5.2bn which is a drop of 58% compared to the same period in 2022.